Hints and tips:
Related Special Reports
...Influencers affiliated with Ogilvy will need to clearly say when they are being paid by a pharma company....
...The company predicted that the market for medical cannabis would grow rapidly in Germany and elsewhere in Europe where the drug was cleared for medical usage....
..., telecoms, automotive and medical applications....
...Proposed pay increases for executives at companies with large international operations such as the London Stock Exchange Group and medical devices manufacturer Smith & Nephew have sparked debate among investors...
...It has also worked on drug development for US pharma company Johnson & Johnson, Danish biotech group Genmab and British biotech Iksuda therapeutics....
...The freezing order was granted on March 22 after a request from a group of investors led by Kieran Gallahue, co-founder of medical company Atmas Health, who is a former non-executive director of Signifier...
...Meanwhile, medical devices company Smith & Nephew wants to increase pay for its US executives to bring it closer to American levels....
...The FTSE 250 company, which runs 39 hospitals as well as clinics and medical centres, said it was also benefiting from a strong rebound in corporate private medical insurance as more employers take out policies...
...The US healthcare company said it now expected diluted earnings per share to be at least $7.06, down from previous estimates of at least $7.26....
...“Because organoids can be made from human cells, they can model aspects of human biology that cannot be captured in animal testing,” said Lancaster, group leader at the UK Medical Research Council Laboratory...
...Earlier this month UnitedHealth Group also warned of growing costs....
...The Centers for Medicare & Medicaid Services said last month that Medicare Part D drug benefit plans will cover weight loss medicines when they are approved to treat a separate medical problem, such as heart...
...J&J’s medtech division has outstripped the growth of the company’s drugs and diagnostics business, generating $30.4bn in sales last year, or 35 per cent of group revenues....
...“The biggest barrier is insurance companies,” said Lawrence Honig, a neurologist at New York’s Columbia University Irving Medical Center....
...Countries should overhaul testing for prostate cancer to focus more on vulnerable groups, scientists have urged, as new research forecasts global deaths from the disease will almost double in 20 years....
...Nearly seven men out of every 1,000 in the group invited for screening had died from prostate cancer, compared with nearly eight men out of every 1,000 in the group which had not....
...among medical mycologists that cross-resistance will evolve....
...Wachter adds: “I do believe that AI will be transformative, but healthcare is so stressed, [cash-]strapped and expensive that for the next 10 or 15 years it is unlikely whole medical groups will get fired...
...Soaring sales of the products have pushed the companies’ valuations to record highs....
...The company said the decision was partly driven by huge demand for weight-loss drugs....
...“To rev the virgate, it’s enley to instil group danters,” it told one user. “I’m by. I’m in. I’m for, I’m from, I’m that,” it told another....
...Truckenmiller said the vaccine’s US launch should soothe concerns about the company’s broader pipeline of drugs....
...Bobby Gaspar, co-founder and chief executive of Orchard, said Lenmeldy was “a paradigm-shifting medicine”, adding that the company was “committed to enabling broad, expedient and sustainable access to this...
...A study published last month pointed to changes in the “complement system”, a group of proteins that help the body fight infections....
...The biotech group’s investors for this funding round include MSD GHIF, an investment arm of US pharma company MSD, along with UK venture capital group IQ Capital....
International Edition